06 June 2024
Cambridge Nutritional Sciences PLC
("CNSL" or the "Company")
Grant of Options
CNSL, (AIM:CNSL) the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 6 June 2024 the Board granted share options (the "Options") over its ordinary shares of 4.0 pence each ("Ordinary Shares") to the Chair, Carolyn Rand, Non-Executive Director, and to Jeremy Millard, Non-Executive Director.
Following this grant of Options, the Company has options in issue over 18,184,049 Ordinary Shares, representing approximately 8% per cent. of the Company's total issued share capital.
Director |
Number of Options granted on |
Exercise Price |
Total options held |
|
9,930,000 |
4.0p |
9,930,000 |
Jeremy Millard |
450,000 |
4.0p |
783,334 |
Grant of Options
The Company has granted the Options to incentivise non-executive director ("NED") performance for the benefit of all Shareholders and to more effectively reward active NED engagement.
The Options are subject to time conditions (as set out below); good/bad leaver provisions; and being a director of the Company on the date of vesting.
Vesting criteria for Options are subject to time conditions as follows:
Amount Vesting |
Time Condition |
34 per cent. ("Tranche One") |
On the first anniversary of 6 June 2024 |
33 per cent. ("Tranche Two") |
On the second anniversary of 6 June 2024 |
33 per cent. ("Tranche Three") |
On the third anniversary of 6 June 2024 |
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).
For further information, please contact:
Cambridge Nutritional Sciences Plc Jag Grewal, Chief Executive Officer
|
investors@cnsplc.com |
Cavendish Capital Markets Limited Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) Nigel Birks / Harriet Ward (ECM) |
Tel: 020 7220 0500 |
About Cambridge Nutritional Sciences Plc
Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Carolyn Rand |
||||
2. |
Reason for the notification |
|||||
a) |
Position/status |
Chair, Non-Executive Chair |
||||
b) |
Initial notification/ |
Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Cambridge Nutritional Sciences plc |
||||
b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the |
Options over Ordinary Shares of 4.0p each |
||||
Identification code |
ISIN: GB00B1VCP282 |
|||||
b) |
Nature of |
Grant of Options |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
n/a |
||||
e) |
Date of the |
6 June 2024 |
||||
f) |
Place of the transactions |
Outside a trading venue |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
Name |
Jeremy Millard |
||||
2. |
Reason for the notification |
|||||
a) |
Position/status |
Non-Executive Director |
||||
b) |
Initial notification/ |
Initial Notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Cambridge Nutritional Sciences plc |
||||
b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the |
Options over Ordinary Shares of 4.0p each |
||||
Identification code |
ISIN: GB00B1VCP282 |
|||||
b) |
Nature of |
Grant of Options |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
n/a |
||||
e) |
Date of the |
6 June 2024 |
||||
f) |
Place of the transactions |
Outside a trading venue |